PURPOSE: To determine whether the main mitochondrial DNA (mtDNA) haplogroups of the Han people are associated with neurological recovery from septic encephalopathy. METHODS: We studied 137 individuals with septic encephalopathy who were sequentially admitted to the intensive care unit or the emergency intensive care unit at the First Affiliated Hospital, College of Medicine, Zhejiang University, and the People's Hospital of Zhejiang Province. Demographic and clinical data were recorded along with clinical outcome over 28 days. The Glasgow coma scale (GCS) score was calculated daily until it reached 15 or until the patient died during the 28-day period. Follow-up was completed for all study participants. We then determined the mtDNA haplogroups of the patients by analyzing sequences of hypervariable mtDNA segments and testing diagnostic polymorphisms in the mtDNA coding region with DNA probes. RESULTS: MtDNA haplogroup R, one of the main mtDNA haplogroups of the Han people, was a strong independent predictor of outcome following septic encephalopathy, conferring a 4.053-fold (95% CI 1.803-9.110, p = 0.001) increased chance of neurological recovery within 28 days compared with those with a non-R mtDNA haplogroup. CONCLUSION: In the Han population, mtDNA haplogroup R is a strong independent predictor of the outcome of septic encephalopathy, conferring an increased chance of neurological recovery compared with individuals with a non-R haplogroup. Our results provide potential insights into the mechanisms involved in septic encephalopathy, and reveal that the mtDNA haplogroup R is an independent predictor of the outcome of septic encephalopathy.
PURPOSE: To determine whether the main mitochondrial DNA (mtDNA) haplogroups of the Han people are associated with neurological recovery from septic encephalopathy. METHODS: We studied 137 individuals with septic encephalopathy who were sequentially admitted to the intensive care unit or the emergency intensive care unit at the First Affiliated Hospital, College of Medicine, Zhejiang University, and the People's Hospital of Zhejiang Province. Demographic and clinical data were recorded along with clinical outcome over 28 days. The Glasgow coma scale (GCS) score was calculated daily until it reached 15 or until the patient died during the 28-day period. Follow-up was completed for all study participants. We then determined the mtDNA haplogroups of the patients by analyzing sequences of hypervariable mtDNA segments and testing diagnostic polymorphisms in the mtDNA coding region with DNA probes. RESULTS: MtDNA haplogroup R, one of the main mtDNA haplogroups of the Han people, was a strong independent predictor of outcome following septic encephalopathy, conferring a 4.053-fold (95% CI 1.803-9.110, p = 0.001) increased chance of neurological recovery within 28 days compared with those with a non-R mtDNA haplogroup. CONCLUSION: In the Han population, mtDNA haplogroup R is a strong independent predictor of the outcome of septic encephalopathy, conferring an increased chance of neurological recovery compared with individuals with a non-R haplogroup. Our results provide potential insights into the mechanisms involved in septic encephalopathy, and reveal that the mtDNA haplogroup R is an independent predictor of the outcome of septic encephalopathy.
Authors: E Ruiz-Pesini; A C Lapeña; C Díez-Sánchez; A Pérez-Martos; J Montoya; E Alvarez; M Díaz; A Urriés; L Montoro; M J López-Pérez; J A Enríquez Journal: Am J Hum Genet Date: 2000-08-09 Impact factor: 11.025
Authors: Eduardo Ruiz-Pesini; Dan Mishmar; Martin Brandon; Vincent Procaccio; Douglas C Wallace Journal: Science Date: 2004-01-09 Impact factor: 47.728
Authors: Simon V Baudouin; David Saunders; Watcharee Tiangyou; Joanna L Elson; Jayne Poynter; Angela Pyle; Sharon Keers; Douglass M Turnbull; Neil Howell; Patrick F Chinnery Journal: Lancet Date: 2005-12-17 Impact factor: 79.321
Authors: Joana da Costa P d'Avila; Ana Paula S A Santiago; Rodrigo T Amâncio; Antonio Galina; Marcus F Oliveira; Fernando A Bozza Journal: Crit Care Med Date: 2008-06 Impact factor: 7.598
Authors: David C Samuels; Todd Hulgan; Joshua P Fessel; Frederic T Billings; Jennifer L Thompson; Rameela Chandrasekhar; Timothy D Girard Journal: Crit Care Med Date: 2019-08 Impact factor: 7.598
Authors: Todd M Manini; Thomas W Buford; John A Kairalla; Mary M McDermott; Carlos A Vaz Fragoso; Roger A Fielding; Fang-Chi Hsu; Neil Johannsen; Stephen Kritchevsky; Tamara B Harris; Anne B Newman; Steven R Cummings; Abby C King; Marco Pahor; Adam J Santanasto; Gregory J Tranah Journal: Geroscience Date: 2018-10-18 Impact factor: 7.713
Authors: Massimo Antonelli; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Daniel De Backer; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2012-01-04 Impact factor: 17.440
Authors: Leonardo Lorente; Ruth Iceta; María M Martín; Esther López-Gallardo; Jordi Solé-Violán; José Blanquer; Lorenzo Labarta; César Díaz; Juan María Borreguero-León; Alejandro Jiménez; Julio Montoya; Eduardo Ruiz-Pesini Journal: PLoS One Date: 2013-09-12 Impact factor: 3.240